Apyx Medical Corp
General ticker "APYX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $56.5M
Apyx Medical Corp does not follow the US Stock Market performance with the rate: -24.6%.
Estimated limits based on current volatility of 4.9%: low 1.52$, high 1.68$
Factors to consider:
- US accounted for 70.1% of revenue in the fiscal year ended 2022-12-31
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.53$, 3.50$]
- 2024-12-30 to 2025-12-30 estimated range: [1.86$, 3.99$]
Financial Metrics affecting the APYX estimates:
- Negative: Non-GAAP EPS, $ of -0.53 <= 0.10
- Negative: Operating profit margin, % of -24.79 <= 1.03
- Negative: Operating cash flow per share per price, % of -6.03 <= 2.35
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Negative: negative Net income
Short-term APYX quotes
Long-term APYX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $48.52MM | $44.51MM | $52.35MM |
| Operating Expenses | $62.97MM | $68.07MM | $69.61MM |
| Operating Income | $-14.45MM | $-23.56MM | $-17.26MM |
| Non-Operating Income | $-0.37MM | $0.65MM | $-4.02MM |
| Interest Expense | $0.01MM | $0.01MM | $2.48MM |
| R&D Expense | $4.32MM | $4.54MM | $4.84MM |
| Income(Loss) | $-14.82MM | $-22.91MM | $-21.28MM |
| Taxes | $0.38MM | $0.37MM | $-2.57MM |
| Profit(Loss) | $-15.20MM | $-23.28MM | $-18.71MM |
| Stockholders Equity | $53.70MM | $37.58MM | $26.70MM |
| Inventory | $6.78MM | $11.80MM | $9.92MM |
| Assets | $68.72MM | $51.77MM | $79.24MM |
| Operating Cash Flow | $-10.45MM | $-20.28MM | $-5.25MM |
| Capital expenditure | $0.72MM | $1.01MM | $0.53MM |
| Investing Cash Flow | $-0.72MM | $-1.01MM | $6.73MM |
| Financing Cash Flow | $0.02MM | $0.22MM | $32.17MM |
| Earnings Per Share* | $-0.44 | $-0.67 | $-0.54 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.